World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: PACTR
Last refreshed on: 29 April 2013
Main ID:  PACTR201210000420221
Date of registration: 26/09/2012
Primary sponsor: Effective Care Research Unit
Public title: Effects of the copper intrauterine device and injectable progestogen contraceptive on depression and sexual functioning
Scientific title: A randomised control trial studying the effects of the copper intrauterine device and injectable progestogen contraceptive on depression and sexual functioning of women in the Eastern Cape
Date of first enrolment: 2012-10-15
Target sample size: 200
Recruitment status: Not yet recruiting
URL:  HTTP://www.pactr.org/ATMWeb/appmanager/atm/atmregistry?da=true&tno=PACTR201210000420221
Study type:  interventional
Study design:  Single group: all participants receive same intervention throughout study,
Randomised,
simple randomisation using a randomisation table created by a computer program ,
Sealed opaque envelopes,
 
Countries of recruitment
South Africa
Contacts
Name: Mandisa  Singata
Address:  Room 68 Admin Block, Cecilia Makiwane Hospital,Mdantsane 5201 East London South Africa
Telephone: +27 43 708 2134
Email: mandisa.singata@gmail.com
Affiliation:  Deputy Director
Name: Mandisa  Singata
Address:  Room 68 Admin Block, Cecilia Makiwane Hospital,Mdantsane 5201 East London South Africa
Telephone: +27 43 708 2134
Email: mandisa.singata@gmail.com
Affiliation:  Deputy Director
Key inclusion & exclusion criteria
Inclusion criteria: Women of child bearing age between 18 to 35 years
Women with no evidence of active pelvic infection
Women who have no contraindications to injectable Progestogen or IUD
Women who are prepared to use either method of contraception
Women delivered less than 48 ago.
Women who are willing and able to give consent.

Exclusion criteria: Recent noticed vaginal bleeding that is unusual.
Any contraindication for deport injection and IUD as stated on the WHO contraceptive eligibility criteria will.
Women at baseline screening with depression score of 29 - 63(severe depression)
Women with no access to telephone


Age minimum: 18 Year
Age maximum: 35 Year
Gender: Female
Health Condition(s) or Problem(s) studied

depression,sectual functioning
Intervention(s)
Primary Outcome(s)
depression and sexual functioning
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
Effective Care Research Unit
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history